Adrian Quartel
Equibles does not estimate personal net worth.
Get an email with a short summary when Spruce Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get SPRB alertsAbout Adrian Quartel
Spruce Biosciences, Inc. reported in an 8-K filed July 27, 2026 that Adrian Quartel was appointed Chief Medical Officer, effective July 27, 2026. Spruce Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Spruce Biosciences, Inc. includes Javier Szwarcberg (CEO and Board Member), Michael Grey (Chairman), Samir Gharib (CFO) and 3 others.
“On July 27, 2026, Spruce Biosciences, Inc. (the “Company”) appointed Adrian Quartel, M.D., FFPM, as the Company’s Chief Medical Officer, replacing Dr. Kirk Ways, who had been serving as the Company’s Interim Chief Medical Officer.”
Affiliation history
-
Spruce Biosciences, Inc. (SPRB)
SEC 8-K
Current2026-07-27–present
Company network
Leadership on record at Spruce Biosciences, Inc.
- Javier Szwarcberg CEO, Board Member
- Michael Grey Chairman
- Samir Gharib CFO
- Keli Walbert Board Member
- Kirk Ways, M.D., Ph.D. Board Member
- Percival Barretto-Ko Board Member